ストックスクリーナーアプリを入手
43.37
1.55%
0.6617
プレマーケット:
44.05
0.68
+1.57%
前日終値:
$42.71
開ける：
$43.34
24時間の取引高:
6,242
Relative Volume:
0.27
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.98%
1か月 パフォーマンス:
-5.61%
6か月 パフォーマンス:
+15.61%
1年 パフォーマンス:
+139.75%
1日の値動き範囲:
$42.86
$43.37
1週間の範囲:
$40.94
$43.96
52週間の値動き範囲:
$17.67
$48.18
Virtus Biotech Clinical Trials Etf Stock (BBC) Company Profile
Compare BBC vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Biotech Clinical Trials Etf
|
43.37 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.46 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
750.59 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
754.03 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
292.90 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
730.28 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Biotech Clinical Trials Etf (BBC) 最新ニュース
(BBC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Kodiak Sciences Inc stock (US50012K1051): earnings loss widens as biotech pushes retina pipeline - AD HOC NEWS
Inhibrx Inc stock (US45720L1070): Biotech firm in Virtus ETF holdings - AD HOC NEWS
Anatomy of an AI Trade: How I Use AI to Make Money in Stocks - Money Talks News
(BBC) Risk Channels and Responsive Allocation - Stock Traders Daily
(BBC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Virtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.6554 - MSN
Biotech ETF (BBC) touches fresh 52-week high - MSN
Liquidity Mapping Around (BBC) Price Events - Stock Traders Daily
Biotech ETF (BBC) Touches Fresh 52-Week High - TradingView
Why (BBC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Virtus Biotech Clinical Trials Etf Share Price (BBC.US) - London South East
Understanding Momentum Shifts in (BBC) - Stock Traders Daily
Biotech Stocks and Longevity Investing: Trends To Track - Newsweek
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - AOL.com
Biotech stocks and longevity investing: Trends to track - Laclede County Record
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
Avoiding Lag: Real-Time Signals in (BBC) Movement - Stock Traders Daily
Discipline and Rules-Based Execution in BBC Response - Stock Traders Daily
Stock List: Research Stocks from Around the World - GuruFocus
BBC Technical Analysis & Stock Price Forecast - Intellectia AI
BBC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Behavioral Patterns of BBC and Institutional Flows - Stock Traders Daily
Wall Street Thinks These 4 Biotech Stocks Will Double–At Least–This Year - AOL.com
Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million - AOL.com
(BBC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
How (BBC) Movements Inform Risk Allocation Models - Stock Traders Daily
Trading Systems Reacting to (BBC) Volatility - Stock Traders Daily
Why ImmunityBio Stock Is Skyrocketing Again Today - AOL.com
How Virtus Lifesci Biotech Clinical Trials Etf (BBC) Affects Rotational Strategy Timing - Stock Traders Daily
What's Going On With Alumis Stock Thursday? - Sahm
Daily News - FinancialContent
Los Angeles Daily NewsVirtus LifeSci Biotech Clinical Trials ETF (NYSE:BBC) Stock Quote - FinancialContent
Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026? - TradingView — Track All Markets
Biotech ETF (BBC) Hits New 52-Week High - MSN
(BBC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears - Sahm
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - Yahoo Finance
Best-Performing ETFs of Last Week: Healthcare Rules - TradingView
Intellia Therapeutics: A Worst-Case Risk Becomes A Tragic Reality (Downgrade) - Seeking Alpha
Best-Performing ETFs of Last Week - Zacks Investment Research
Virtus Biotech Clinical Trials Etf (BBC) 財務データ
Virtus Biotech Clinical Trials Etf (BBC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.58%
大文字化:
|
ボリューム (24 時間):